New SIRT2 inhibitors: Histidine-based bleomycin spin-off

This publication has 37 references indexed in Scilit:

• Trastuzumab — Mechanism of Action and Use in Clinical Practice
  New England Journal of Medicine, 2007
• Bleomycins: towards better therapeutics
  Nature Reviews Cancer, 2005
• Targeted cancer therapy
  Nature, 2004
• Synthetic inhibitors of regulatory proteins involved in the signaling pathway of the replication of human immunodeficiency virus 1
  Bioorganic & Medicinal Chemistry, 1997
• Synthesis and evaluation of deglycobleomycin A2 analogues containing a tertiary N-methyl amide and simple ester replacement for the l-histidine secondary amide: Direct functional characterization of the requirement for secondary amide metal complexation
  Bioorganic & Medicinal Chemistry, 1996
• Metal-Chelating Inhibitors of a Zinc Finger Protein HIV-EP1. Remarkable Potentiation of Inhibitory Activity by Introduction of SH Groups
  Journal of Medicinal Chemistry, 1996
• Restructuring of the bleomycin metal core. Novel oxygen-activating ligands with symmetrized structure
  Tetrahedron Letters, 1993
• Transition-metal binding site of bleomycin. A remarkably efficient dioxygen-activating molecule based on bleomycin-Fe(II) complex
  Tetrahedron Letters, 1986
• Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
  International Journal of Cancer, 1976
• α-Lactalbumin Production in Human Mammary Carcinoma
  Science, 1975